Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., West Virginia University 2000
• 

  Duke Appointment History

  • Assistant Consulting Professor of Child & Adolescent Psychiatry in the Department of Psychiatry and Behavioral Sciences, Psychiatry, Child & Family Mental Health and Developmental Neuroscience, Psychiatry & Behavioral Sciences 2007 - 2008
• Recognition
• 

  In the News

  • MAR 30, 2015

    Macleans

    The science is in: God is the answer
• Research
• 

  Selected Grants

  • Pfizer Open Label 1019 awarded by Pfizer, Inc. 2018 - 2020
  • Pfizer Double-Blind 1017 awarded by Pfizer, Inc. 2018 - 2020
  • Paternal Transgenerational Epigenetic Legacy from Use of Cannabis awarded by John Templeton Foundation 2017 - 2020
  • Neurobehavioral substrates of propranolol's effects on drug cue reactivity awarded by National Institutes of Health 2017 - 2019
  • Environment Cue-Reactivity: Brain, Behavior and Clinical Outcomes in Tobacco Use awarded by National Institutes of Health 2014 - 2019
  • KP415.E01 Analog Classroom awarded by KemPharm, Inc 2017 - 2018
  • Behavioral and genetic mechanisms of smoking risk in individuals with ADHD awarded by National Institutes of Health 2012 - 2018
  • Rhodes Preschool pK awarded by Rhodes Pharmaceuticals L.P. 2015 - 2018
  • SPD 489-348 Preschool Open Label Follow-Up awarded by Shire Pharmaceutical Development US Inc. 2015 - 2017
  • SPD489-211 Preschool pK Study awarded by Shire Pharmaceutical Development US Inc. 2015 - 2017
  • SEP360-202 awarded by Sunovion Pharmaceuticals, Inc 2015 - 2017
  • Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2015 - 2017
  • Ironshore_HLD200-108 awarded by Ironshore Pharmaceuticals & Development, Inc 2015 - 2016
  • An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2015 - 2016
  • SEP-225289 in Adults with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2014 - 2016
  • Neurovance_Adult Workplace Environment awarded by Neurovance 2015 - 2016
  • SEP-225289 in Subjects 6 to 17 Years of Age with Attention Deficit Hyperactivity Disorder awarded by Sunovion Pharmaceuticals, Inc 2015
  • Purdue Adolescent awarded by Purdue Pharma L.P. 2014 - 2015
  • Purdue Adult awarded by Purdue Pharma L.P. 2014 - 2015
  • Purdue Open Label awarded by Purdue Pharma L.P. 2014 - 2015
  • Ironshore Classroom Study awarded by Ironshore Pharmaceuticals & Development, Inc 2014 - 2015
  • Alcobra AL012 awarded by Alcobra Ltd. 2014 - 2015
  • Tris classroom awarded by Tris Pharma, Inc. 2014 - 2015
  • Neuropharmacology of Response Inhibition in Comorbid ADHD and Nicotine Dependence awarded by National Institutes of Health 2009 - 2014
  • Brain Substrates of Extinction-Based Treatment for Nicotine Dependence awarded by National Institutes of Health 2008 - 2014
  • Smoking reinforcement in adults with and without ADHD awarded by National Institutes of Health 2009 - 2012
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Kollins, SH, Schoenfelder, EN, English, JS, Holdaway, A, Van Voorhees, E, O'Brien, BR, Dew, R, and Chrisman, AK. "An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults." Journal of Substance Abuse Treatment 48, no. 1 (January 2015): 96-103.  Full Text
    • Kollins, SH, Schoenfelder, EN, English, JS, Holdaway, A, Van Voorhees, E, O'Brien, BR, Dew, R, and Chrisman, AK. "An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults." Journal of Substance Abuse Treatment 48, no. 1 (January 1, 2015): 96-103.  Full Text
    • Kollins, SH, English, JS, Itchon-Ramos, N, Chrisman, AK, Dew, R, O'Brien, B, and McClernon, FJ. "A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD." Journal of attention disorders 18, no. 2 (February 2014): 158-168.  Full Text
    • Kollins, SH, Schoenfelder, E, English, JS, McClernon, FJ, Dew, RE, and Lane, SD. "Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD)." Exp Clin Psychopharmacol 21, no. 5 (October 2013): 375-384.  Full Text  Link to Item
    • Blalock, L, and Dew, RE. "A pilot survey of clergy regarding mental health care for children." Depress Res Treat 2012 (2012): 742410-.  Full Text  Link to Item
    • Bonelli, R, Dew, RE, Koenig, HG, Rosmarin, DH, and Vasegh, S. "Religious and Spiritual Factors in Depression: Review and Integration of the Research." Depression Research and Treatment 2012 (2012): 1-8.  Full Text
    • Vasegh, S, Rosmarin, DH, Koenig, HG, Dew, RE, and Bonelli, RM. "Religious and spiritual factors in depression." Depression Research and Treatment 2012 (2012).  Full Text
    • Voorhees, EV, McClernon, FJ, Fuemmeler, B, English, J, Holdaway, A, Hallyburton, M, Dew, R, and Kollins, S. "An examination of differences in variables maintaining smoking behavior in adult smokers with and without attention-deficit/hyperactivity disorder." Addiction Research and Theory 20, no. 1 (2012): 72-81.  Full Text
    • Bidwell, LC, Dew, RE, and Kollins, SH. "Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder." Curr Psychiatry Rep 13, no. 1 (February 2011): 76-.  Full Text  Link to Item
    • Dew, RE, and Kollins, SH. "Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD." Expert Opin Pharmacother 11, no. 17 (December 2010): 2907-2913. (Review)  Full Text  Link to Item
    • Cinnamon Bidwell, L, Dew, RE, and Kollins, SH. "Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder." Curr Psychiatry Rep 12, no. 5 (October 2010): 366-373. (Review)  Full Text  Link to Item
    • Dew, RE, Daniel, SS, Goldston, DB, McCall, WV, Kuchibhatla, M, Schleifer, C, Triplett, MF, and Koenig, HG. "A prospective study of religion/spirituality and depressive symptoms among adolescent psychiatric patients." Journal of Affective Disorders 120, no. 1-3 (January 2010): 149-157.  Full Text
    • Dew, RE. "Why Psychiatry Is the Hardest Specialty." AMERICAN JOURNAL OF PSYCHIATRY 166, no. 1 (January 2009): 16-17.  Full Text  Link to Item
    • Dew, RE, Daniel, SS, Armstrong, TD, Goldston, DB, Triplett, MF, and Koenig, HG. "Religion/Spirituality and adolescent psychiatric symptoms: a review." Child Psychiatry and Human Development 39, no. 4 (December 2008): 381-398. (Review)  Full Text
    • Dew, RE, Daniel, SS, Goldston, DB, and Koenig, HG. "Religion, spirituality, and depression in adolescent psychiatric outpatients." The Journal of Nervous and Mental Disease 196, no. 3 (March 2008): 247-251.  Full Text
    • Dougherty, DM, Dew, RE, Mathias, CW, Marsh, DM, Addicott, MA, and Barratt, ES. "Impulsive and premeditated subtypes of aggression in conduct disorder: differences in time estimation." Aggress Behav 33, no. 6 (November 2007): 574-582.  Full Text  Link to Item
    • Dew, RE, Daniel, SS, and Koenig, HG. "A pilot study on religiousness/spirituality and ADHD." Int J Adolesc Med Health 19, no. 4 (October 2007): 507-510.  Link to Item
    • Dew, RE. "Informed consent for research in Borderline Personality Disorder. (Published online)" BMC Med Ethics 8 (May 10, 2007): 4-.  Full Text  Link to Item
    • Dew, RE, Kramer, SI, and McCall, WV. "Adequacy of antidepressant treatment by psychiatric residents: the antidepressant treatment history form as a possible assessment tool." Acad Psychiatry 29, no. 3 (July 2005): 283-288.  Full Text  Link to Item
    • Dew, RE, Rosenquist, PB, and McCall, WV. "Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome." Int J Adolesc Med Health 17, no. 2 (April 2005): 187-188.  Link to Item
    • Dew, RE, Kimball, JN, Rosenquist, PB, and McCall, WV. "Seizure length and clinical outcome in electroconvulsive therapy using methohexital or thiopental." J ECT 21, no. 1 (March 2005): 16-18.  Link to Item
    • Dew, RE, and Hughes, D. "Acute dystonic reaction with moderate-dose ziprasidone." J Clin Psychopharmacol 24, no. 5 (October 2004): 563-564. (Letter)  Link to Item
    • Dew, R, and McCall, WV. "Efficiency of outpatient ECT." J ECT 20, no. 1 (March 2004): 24-25.  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.